Orbimed Advisors LLC

10% OwnerEnliven Therapeutics, Inc. (ELVN) · full profile →Form 4 · filed Jun 24, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$39.0M
Net Open-Market Flow
-$39.0M
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 22, 2026Sell(S)25K$45.38$1.1M221K
Jun 22, 2026Sell(S)1K$45.00$66K219K
Jun 22, 2026Sell(S)787K$45.38$35.7M6.6M
Jun 22, 2026Sell(S)47K$45.00$2.1M6.6M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000947871-26-000653) within minutes of acceptance. Every field above traces to the original document. Verify it directly: